Skip to main

Posts & Investments - #medicaladvances

Invested in Geovax Labs
#medicaladvances
6
0
DermTech $DMTK Although this stock has tripled in 2023, there could be more room to run. This genomics co has a melanoma test that involves no cutting. It is called the smart stickers process. Here are the current & future catalysts : FDA approved Non invasive Recently accepted by major insurance: Blue Cross Blue Shield, among See more
Dec 19, 2022 - Jan 18, 2023
DMTK
DMTK159.22%
4
0
Sold DermTech IncInvested for 552 days
Made21.75%
0
0
Tipped
0
0
Sold Vanguard S&P 500 ETFInvested for 185 days
Lost2.73%
Tipped
0
0

Elon Musk’s neurotechnology company Neuralink submitted paperwork to the US government 🇺🇸 to conduct human trials with their brain implant chip. If approved, they’re hoping to start implanting their microchip into participants' brains 🧠 within six months 🗓️. Would you sign up? (1/2) #neuralink #neurotechnology #elonmusk #science #medical #technology #medicaladvances #oportunity

Yep. Sign me up! 22.22%
It depends on…4.44%
Absolutely not! 57.78%
Too soon! More research!15.56%
45 votes Ended 12/08/22
3
0
👩🏽‍⚕️🧑🏻‍⚕️ Medical Minute 💊🔬 Medical advances are happening at an exponential pace. Following patents, fda approvals, trials, and mergers/acquisitions are some things I like to look for. Here are a few for 4th Quarter. 🩺💉 https:/www.biopharmadive.com/news/5-fda-approval-decisions-fourth-quarter-2022/632732/ I am watching See more
Oct 10 - Oct 14, 2022
GSK
GSK2.03%
MRK
MRK5.51%
ABBV
ABBV4.18%
LLY
LLY1.51%
11
0
Own your future.
Build your portfolio.
Products
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2023 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured. Apex Clearing Corporation, our clearing firm, has additional insurance coverage in excess of the regular SIPC limits. Additional information can be found here

Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). This content is not investment advice. These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. Alternative Assets purchased on the Public platform are not held in an Open to the Public Investing brokerage account and are self-custodied by the purchaser. The issuers of these securities may be an affiliate of Public, and Public (or an affiliate) may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures, Apex Crypto.

Dalmore and Apex Crypto, LLC are not affiliated with any of the Public Holdings subsidiaries. Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S.-listed, registered securities electronically during the Regular Trading Hours. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

Fractional shares are illiquid outside of Public and not transferable. For a complete explanation of conditions, restrictions and limitations associated with fractional shares, see our Fractional Share Disclosure to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.